Eight-Year Experience of Hedgehog Pathway Inhibitors at Three Tertiary Referral Centres in the Australian State of Victoria. [PDF]
Australas J DermatolGan C +4 more
europepmc +1 more source
Efficacy and safety of vismodegib in periocular and orbital basal cell carcinoma: a systematic review and meta-analysis. [PDF]
Front Med (Lausanne)Alessa D.
europepmc +1 more source
3-Oxabicyclo[3.1.1]heptane as an Isostere of meta-Benzene. [PDF]
Angew Chem Int Ed EnglDibchak D, Mykhailiuk PK.
europepmc +1 more source
In vivo sonic hedgehog pathway antagonism temporarily results in ancestral proto-feather-like structures in the chicken. [PDF]
PLoS BiolCooper RL, Milinkovitch MC.
europepmc +1 more source
Advances in Targeted and Immunotherapy for High-Risk Cutaneous Malignancies. [PDF]
Oncol ResPetty AJ, Emge DA, Cardones AR.
europepmc +1 more source
Advanced Basal Cell Carcinoma: A Narrative Review on Current Systemic Treatments and the Neoadjuvant Approach. [PDF]
J Pers MedParadisi A +5 more
europepmc +1 more source
Locally advanced basal cell carcinoma treated with sonidegib: <i>in vivo</i> monitoring with line-field confocal optical coherence tomography. [PDF]
Skin Health DisCappilli S +7 more
europepmc +1 more source
Secondary resistance to sonidegib is rare in locally advanced basal cell carcinoma. [PDF]
J Eur Acad Dermatol VenereolMuñoz Couselo E +5 more
europepmc +1 more source
Efficacy and safety of sonidegib in the treatment of locally advanced basal cell carcinoma: A multicenter retrospective experience in real-world China. [PDF]
Chin Med J (Engl)Luan J +7 more
europepmc +1 more source
Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. [PDF]
Cancers (Basel)Karaulic A, Fournier C, Pagès G.
europepmc +1 more source